Patients with acute or critical illnesses are susceptible to developing malnutrition, either as a direct result of the disease or due to treatment adverse effects (ADs)1. While disease-related malnutrition (DRM) is associated with various adverse ou...
AL Amyloidosis: A Rare but Multifaceted Disease Light chain (AL) amyloidosis is a rare multi-systemic, incurable protein misfolding disorder characterised by plasma cell dyscrasia and abnormal clonal plasma cell proliferation 1 . Immunoglobulin secr...
Long-term treatment with nucleos(t)ide analogues (NA) is essential for patients with chronic hepatitis B (CHB) to control hepatitis B virus (HBV) infection and reduce the risks of sequelae including cirrhosis, hepatic decompensation, and hepatocellu...
Long-term treatment with nucleos(t)ide analogues (NA) is essential for patients with chronic hepatitis B (CHB) to control hepatitis B virus (HBV) inf...
Long-term treatment with nucleos(t)ide analogues (NA) is essential for patients with chronic hepatitis B (CHB) to control hepatitis B virus (HBV) inf...
Long-term treatment with nucleos(t)ide analogues (NA) is essential for patients with chronic hepatitis B (CHB) to control hepatitis B virus (HBV) inf...
Long-term treatment with nucleos(t)ide analogues (NA) is essential for patients with chronic hepatitis B (CHB) to control hepatitis B virus (HBV) inf...
Psoriasis is a chronic immune-mediated disease of the skin, with wide dermatological manifestations...
Atherosclerosis and osteoporosis are major age-related diseases, predominantly contributing to sign...
Understanding the molecular mechanisms of different diseases allows us to develop novel medicines. ...
Asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) are often said to be analogous to sibl...
Atopic dermatitis (AD), one of the most common skin conditions worldwide, has shown an increasing s...
The treatment landscape of acute myeloid leukaemia (AML) is constantly evolving, and a new form of ...
CME: 1 point
Deadline: 15 Mar 2024
Renal cell carcinomas (RCCs) are the most common type of kidney cancer in adults and is prevalent in adult male aged between 60 and 70.